Lin J - Search Results

1

Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab.

Shang X, Li Z, Sun J, Zhao C, Lin J, Wang H. Shang X, et al. Among authors: lin j. Lung Cancer. 2021 Apr;154:105-112. doi: 10.1016/j.lungcan.2021.02.010. Epub 2021 Feb 17. Lung Cancer. 2021. PMID: 33640623

2

Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysis.

Lin J, Li C, Zhang C, Shi F, Wang H. Lin J, et al. Future Oncol. 2017 Jul;13(16):1395-1404. doi: 10.2217/fon-2017-0099. Epub 2017 Apr 6. Future Oncol. 2017. PMID: 28381104

3

The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study.

Cai H, Wang H, Li Z, Lin J, Yu J. Cai H, et al. Among authors: lin j. Future Oncol. 2018 Jun;14(14):1397-1407. doi: 10.2217/fon-2017-0706. Epub 2018 Jan 23. Future Oncol. 2018. PMID: 29359568

4

Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis.

Kou P, Wang H, Lin J, Zhang Y, Yu J. Kou P, et al. Among authors: lin j. Future Oncol. 2018 Oct;14(23):2371-2381. doi: 10.2217/fon-2018-0326. Epub 2018 May 29. Future Oncol. 2018. PMID: 29807451

5

Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma.

Chen D, Zhang C, Lin J, Song X, Wang H. Chen D, et al. Among authors: lin j. Cancer Manag Res. 2018 May 18;10:1275-1283. doi: 10.2147/CMAR.S166740. eCollection 2018. Cancer Manag Res. 2018. PMID: 29849467 Free PMC article.

6

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study.

Shang X, Li Z, Lin J, Wang H, Wang Z. Shang X, et al. Among authors: lin j. Cancer Manag Res. 2018 Sep 17;10:3561-3567. doi: 10.2147/CMAR.S173856. eCollection 2018. Cancer Manag Res. 2018. PMID: 30271204 Free PMC article.

7

Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.

Zhang C, Zhang C, Lin J, Wang H. Zhang C, et al. Among authors: lin j. Cell Physiol Biochem. 2018;51(1):290-300. doi: 10.1159/000495230. Epub 2018 Nov 19. Cell Physiol Biochem. 2018. PMID: 30453307 Free article.

8

Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma.

Kou P, Zhang C, Lin J, Wang H. Kou P, et al. Among authors: lin j. Oncol Lett. 2019 Feb;17(2):2091-2098. doi: 10.3892/ol.2018.9863. Epub 2018 Dec 21. Oncol Lett. 2019. PMID: 30675276 Free PMC article.

9

A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.

Shang X, Liu J, Li Z, Lin J, Wang H. Shang X, et al. Among authors: lin j. BMC Cancer. 2019 Jun 17;19(1):591. doi: 10.1186/s12885-019-5797-8. BMC Cancer. 2019. PMID: 31208403 Free PMC article.

10

Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.

Lin J, Fang L, Li H, Li Z, Lyu L, Wang H, Xiao J. Lin J, et al. Eur J Pharmacol. 2019 Sep 15;859:172490. doi: 10.1016/j.ejphar.2019.172490. Epub 2019 Jun 21. Eur J Pharmacol. 2019. PMID: 31229536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,375 results

Search Page

Filters